8-K: Clover Health Wins Star Rating Appeal, Boosts Medicare Contract
Other Events
Clover Health Investments, Corp. announced a favorable court ruling and subsequent recalculation of its 2026 Medicare Star Rating to 4.5 stars, impacting over 97% of its members.
Summary
- Clover Health Investments, Corp. reported a significant legal victory concerning its 2026 Medicare Star Rating.
- A court ruled in favor of Clover Insurance Company, a subsidiary, ordering CMS to recalculate the 2026 Star Rating for Contract H5141.
- The initial 3.5 Star Rating for Contract H5141 has been set aside.
- CMS has recalculated the rating to 4.5 Stars, impacting Clover's PPO plan which covers over 97% of its members.
- This recalculation is for Payment Year 2027.
- Clover's HMO plans (Contract H8010) 2026 Star Rating remains unchanged at 4.0 Stars.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a strongly positive development due to the successful legal outcome and significant improvement in a key performance metric directly impacting revenue potential.
Positives
- Successful appeal of the 2026 Star Rating for a key Medicare contract.
- Recalculated 2026 Star Rating for Contract H5141 (PPO plan) increased to 4.5 Stars from 3.5 Stars.
- The improved rating impacts over 97% of Clover's members through its PPO plan.
- The court order and subsequent recalculation are expected to positively affect future payments for Payment Year 2027.
Negatives
- The initial 3.5 Star Rating for Contract H5141 was deemed insufficient, requiring legal action.
- Clover's HMO plans (Contract H8010) maintained a 4.0 Star Rating, which was not improved by this litigation.
Risks
- The outcome of future legal challenges or regulatory reviews could impact star ratings and payments.
- Dependence on Medicare Star Ratings for a significant portion of revenue creates inherent risk.
- Potential for future changes in CMS rating methodologies or policies.
Future Outlook
The improved 4.5 Star Rating for Contract H5141 is expected to positively influence bids for Payment Year 2027 and potentially impact future revenue streams associated with this contract.
Management Comments
- The court's decision and CMS's subsequent recalculation to 4.5 stars for our PPO plan is a significant positive outcome for Clover Health and our members.
- This validates our efforts to provide high-quality care and service, which is reflected in the improved star rating.
Industry Context
StockSavvy.ai notes that Medicare Star Ratings are critical for health insurers participating in Medicare Advantage and Part D programs, directly impacting reimbursement rates and competitive positioning. A higher star rating can lead to increased member enrollment and better payment adjustments, while lower ratings can result in financial penalties and reduced competitiveness.
Legal Proceedings
- Clover Insurance Co. v. U.S. Department of Health and Human Services, 2:25-CV-142: The United States District Court for the Southern District of Georgia granted summary judgment in part for Clover Insurance Company, ordering CMS to recalculate the 2026 Star Rating for Contract H5141.
Stakeholder Impact
- Shareholders: Potential for improved financial performance due to higher reimbursement rates and increased enrollment attractiveness.
- Members: Continued access to Medicare Advantage plans with a higher quality rating, potentially leading to better benefits and services.
- CMS: Compliance with court orders and adherence to Medicare rating regulations.
Next Steps
- Submit alternate bids at the recalculated 4.5 Star Rating for Contract H5141.
- Continue to manage and improve services to maintain or further enhance star ratings for all contracts.
Key Dates
| Date | Description |
|---|---|
| 2026-05-29 | United States District Court for the Southern District of Georgia entered final judgment in Clover Insurance Co. v. U.S. Department of Health and Human Services, granting summary judgment in part for Clover Insurance Company. |
| 2026-06-09 | CMS informed Clover that it has recalculated Clover's 2026 Star Rating as 4.5 Stars for Contract H5141. |
| 2026-06-10 | Date of the 8-K filing. |
Recommendation
holdWhile the star rating improvement is a significant positive, the filing is an 8-K reporting a legal outcome and rating adjustment rather than new financial results or strategic guidance. The impact on actual financial performance requires further analysis of bid outcomes and operational execution. Therefore, a 'hold' recommendation is appropriate pending more comprehensive financial updates.
Keywords
Clover Health, Medicare Star Rating, CMS, Court Ruling, PPO Plan, HMO Plan, Contract H5141, Payment Year 2027
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.